The Administrator announces the suspension of Gemini as a CME CF Constituent Exchange for the indices below:
The suspension follows Gemini's cessation of support for Synthetix (SNX) on September 20th, 2024. Accordingly, Gemini was suspended as a CME CF Constituent Exchange for the above asset pairs from September 20th, 2023.
Questions or queries regarding this process and decision should be directed to [email protected].
Any complaints regarding this process and decision can be made confidentially by writing to [email protected].
The information contained within is for educational and informational purposes ONLY. It is not intended nor should it be considered an invitation or inducement to buy or sell any of the underlying instruments cited including but not limited to cryptoassets, financial instruments or any instruments that reference any index provided by CF Benchmarks Ltd. This communication is not intended to persuade or incite you to buy or sell security or securities noted within. Any commentary provided is the opinion of the author and should not be considered a personalised recommendation. Please contact your financial adviser or professional before making an investment decision.
Note: Some of the underlying instruments cited within this material may be restricted to certain customer categories in certain jurisdictions.
The Administrator has confirmed changes to the Token Market Price Family for the period 30 June 2026 to 07 July 2026.

CF Benchmarks
The CF Free-Float Broad Cap Index fell 18.29% in June as a Bitcoin-led drawdown overwhelmed a thinning tape. Record ETF outflows, a rare Strategy sale, and a delayed Ethereum upgrade left Settlement assets supplying nearly the entire loss, with diversification offering little cover across the suite.

Mark Pilipczuk
Digital assets rebounded broadly over the past week as a soft US jobs print pared rate-hike fear and ETF flows turned positive. Payments and settlement names led, breadth favored diversified exposure, implied volatility compressed, and Bitcoin front-end funding eased toward its term curve.

Gabriel Selby
By clicking Accept, you consent to CF Benchmarks's use of cookies.
Visit Cookie Settings to learn how CF Benchmarks uses cookies and to adjust your preferences.